ICD-10-CM Diagnosis Code T88.1XXS - Other complications following immunization, not elsewhere classified, sequela (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- S00–T88
- T80-T88
- T88
- 2026 ICD-10-CM Code T88.1XXS
Other complications following immunization, not elsewhere classified, sequela
ICD-10-CM Code:
T88.1XXS
ICD-10 Code for:
Oth complications following immunization, NEC, sequela
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:
T88.1XXS is a billable diagnosis code used to specify a medical diagnosis of other complications following immunization, not elsewhere classified, sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2025 through September 30, 2026. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
T88.1XXS is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like other complications following immunization not elsewhere classified. According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.
- Code Information
- Approximate Synonyms
- Clinical Classification
- Clinical Information
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Diagnostic Related Groups Mapping
- Present on Admission (POA)
- Convert to ICD-9 Code
- Patient Education
- Other Codes Used Similar Conditions
- Code History
- Injury, poisoning and certain other consequences of external causes
S00–T88
The following list of clinical terms are approximate synonyms, alternative descriptions, or common phrases that might be used by patients, healthcare providers, or medical coders to describe the same condition. These synonyms and related diagnosis terms are often used when searching for an ICD-10 code, especially when the exact medical terminology is unclear. Whether you're looking for lay terms, similar diagnosis names, or common language alternatives, this list can help guide you to the correct ICD-10 classification.
- Complication due to immunization
- Complication due to vaccination
- Complication of smallpox vaccination
- Eczema vaccinatum
- Eczema vaccinatum
- Feeling irritable
- Fibrosarcoma
- Generalized vaccinia
- Inadvertent autoinoculation with Vaccinia virus following contact with smallpox vaccination site
- Infection following immunization
- Inflammatory neuropathy due to and following vaccination
- Irritability postvaccinal
- Kaposi's varicelliform eruption caused by Vaccinia virus
- Neurological complication following vaccination
- Neurological complication following vaccination
- Progressive vaccina
- Scar of skin following first vaccination
- Swelling of skin
- Vaccination site cellulitis
- Vaccination site lump
- Vaccination site rash
- Vaccination site swelling
- Vaccination site vaccinia
- Vaccine-induced fibrosarcoma
- Vaccinia
- Vaccinia
- Vaccinia
- Vaccinia keratitis
Clinical Classifications group individual ICD-10-CM diagnosis codes into broader, clinically meaningful categories. These categories help simplify complex data by organizing related conditions under common clinical themes.
They are especially useful for data analysis, reporting, and clinical decision-making. Even when diagnosis codes differ, similar conditions can be grouped together based on their clinical relevance. Each category is assigned a unique CCSR code that represents a specific clinical concept, often tied to a body system or medical specialty.
CCSR Code: INJ076
Inpatient Default: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
Outpatient Default: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Dual Specificity Phosphatase 3
a dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating mitogen-activated protein kinases. it has specificity for extracellular signal-regulated map kinases.
Smallpox Vaccine
a vaccinia virus vaccine used for immunization against smallpox. it is now recommended only for laboratory workers exposed to smallpox virus. certain countries continue to vaccinate those in the military service. rare complications most often associated with older generation smallpox vaccines include vaccinia, secondary bacterial infections, and encephalomyelitis. because monkeypox virus and smallpox virus are both orthopoxvirus and are closely related smallpox vaccines provide effective cross-protection against mpox, monkeypox (https://www.cdc.gov/poxvirus/monkeypox/clinicians/smallpox-vaccine.html).
Vaccinia
the cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine.
Vaccinia virus
the type species of orthopoxvirus, related to cowpox virus, but whose true origin is unknown. it has been used as a live vaccine against smallpox. it is also used as a vector for inserting foreign dna into animals. rabbitpox virus is a subspecies of vaccinia virus.
Dermatofibrosarcoma
a sarcoma of the deep layers of the skin. the tumors are locally aggressive tends to recur but rarely metastatic. it can be classified into variants depending on the cell type tumors are derived from or by its characteristics: pigmented variant from melanin-containing dermal dendritic cells; myxoid variant, myxoid stromal cells; giant cell variant characterized by giant cells in the tumors; and fibrosarcomatous variant chracterized by tumor areas histologically indistinguishable from fibrosarcoma.
Fibrosarcoma
a sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (stedman, 25th ed)
The appropriate 7th character is to be added to each code from block Other complications of surgical and medical care, not elsewhere classified (T88). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
T88.1XXS is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator: Y
Reason: Diagnosis was present at time of inpatient admission.
CMS Pays CC/MCC DRG? YES
POA Indicator: N
Reason: Diagnosis was not present at time of inpatient admission.
CMS Pays CC/MCC DRG? NO
POA Indicator: U
Reason: Documentation insufficient to determine if the condition was present at the time of inpatient admission.
CMS Pays CC/MCC DRG? NO
POA Indicator: W
Reason: Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.
CMS Pays CC/MCC DRG? YES
POA Indicator: 1
Reason: Unreported/Not used - Exempt from POA reporting.
CMS Pays CC/MCC DRG? NO
Below are the ICD-9 codes that most closely match this ICD-10 code, based on the General Equivalence Mappings (GEMs). This ICD-10 to ICD-9 crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.
ICD-9-CM: 909.3
Approximate Flag - The approximate mapping means this ICD-10 code does not have an exact ICD-9 equivalent. The matched code is the closest available option, but it may not fully capture the original diagnosis or clinical intent.
Vaccines
What are vaccines?
Vaccines are injections (shots), liquids, pills, or nasal sprays that you take to teach your body's immune system to recognize and defend against harmful germs. For example, there are vaccines to protect against diseases caused by:
- Viruses, like the ones that cause the flu and COVID-19
- Bacteria, including tetanus, diphtheria, and pertussis
What are the types of vaccines?
There are several types of vaccines:
- Live-attenuated vaccines use a weakened form of the germ.
- Inactivated vaccines use a killed version of the germ.
- Subunit, recombinant, polysaccharide, and conjugate vaccines use only specific pieces of the germ, such as its protein, sugar, or casing.
- Toxoid vaccines use a toxin (harmful product) made by the germ.
- mRNA vaccines use messenger RNA, which gives your cells instructions for how to make a protein (or piece of a protein) of the germ.
- Viral vector vaccines use genetic material, which gives your cells instructions for making a protein of the germ. These vaccines also contain a different, harmless virus that helps get the genetic material into your cells.
These vaccines may work in different ways, but they all spark an immune response. The immune response is the way your body defends itself against substances it sees as foreign or harmful. These substances include germs that can cause disease.
What happens in an immune response?
There are different steps in the immune response:
- When a germ invades, your body sees it as foreign.
- Your immune system helps your body fight off the germ.
- Your immune system also remembers the germ. It will attack the germ if it ever invades again. This "memory" protects you against the disease that the germ causes. This type of protection is called immunity.
What are immunization and vaccination?
Immunization is the process of becoming protected against a disease. But it can also mean the same thing as vaccination, which is getting a vaccine to become protected against a disease.
Why are vaccines important?
Vaccines are important because they protect you against many diseases. These diseases can be very serious. So getting immunity from a vaccine is safer than getting immunity by being sick with the disease.
For a few vaccines, getting vaccinated can actually give you a better immune response than getting the disease would.
But vaccines don't just protect you. They also protect the people around you through community immunity.
What is community immunity?
Community immunity, or herd immunity, is the idea that vaccines can help keep communities healthy.
Normally, germs can travel quickly through a community and make a lot of people sick. If enough people get sick, it can lead to an outbreak. But when enough people are vaccinated against a certain disease, it's harder for that disease to spread to others. This type of protection means that the entire community is less likely to get the disease.
Community immunity is especially important for people who can't get certain vaccines. For example, they may not be able to get a vaccine because they have weakened immune systems. Others may be allergic to certain vaccine ingredients. And newborn babies are too young to get some vaccines. Community immunity can help to protect them all.
Are vaccines safe?
Vaccines are safe. They must go through extensive safety testing and evaluation before they are approved in the United States.
What is a vaccine schedule?
A vaccine, or immunization, schedule lists which vaccines are recommended for different groups of people. It includes who should get the vaccines, how many doses they need, and when they should get them. In the United States, the Centers for Disease Control and Prevention (CDC) publishes the vaccine schedule.
It's important for both children and adults to get their vaccines according to the schedule. Following the schedule allows them to get protection from the diseases at exactly the right time.
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
